Wikidata

(Q39612149)

English

ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis

scientific article published on 27 December 2010

In more languages

Statements

title
ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
21206976
retrieved
13 September 2017
author name string
Yuji Sakuma
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
21206976
retrieved
13 September 2017
Jun Tsunezumi
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
21206976
retrieved
13 September 2017
Yoshiyasu Nakamura
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
21206976
retrieved
13 September 2017
Mitsuyo Yoshihara
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
21206976
retrieved
13 September 2017
Shoichi Matsukuma
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
21206976
retrieved
13 September 2017
Shiro Koizume
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
21206976
retrieved
13 September 2017
Yohei Miyagi
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
21206976
retrieved
13 September 2017
publication date
27 December 2010
1 reference
stated in
Europe PubMed Central
PubMed ID
21206976
retrieved
13 September 2017
page(s)
661-667
1 reference
stated in
Europe PubMed Central
PubMed ID
21206976
retrieved
13 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39612149&oldid=1845415067"